Retina Synthesis

147 Folgen

1. A Real World Analysis of Aflibercept Therapy of Diabetic Macular Edema

   Vom: 14.12.2023
2. Topical Therapy of Diabetic Macular Edema

   Vom: 7.12.2023
3. Mitochrondial Therapy of Intermediate AMD

   Vom: 30.11.2023
4. Safety Considerations in Retinal Gene Therapy

   Vom: 16.11.2023
5. An Oral Agent for Treatment of Diabetic Retinopathy

   Vom: 9.11.2023
6. Intravitreal Gene Therapy with 4D-150

   Vom: 26.10.2023
7. Optogenetics in the Treatment of Retinal Degenerations

   Vom: 19.10.2023
8. Update on the Iluvien System for Treatment of Diabetic Macular Edema

   Vom: 12.10.2023
9. The Ophthea Clinical Trial for Neovascular AMD

   Vom: 5.10.2023
10. Senolytic Therapy for Diabetic Macular Edema

    Vom: 28.9.2023
11. The Port Delivery System for Treating Diabetic Retinopathy

    Vom: 21.9.2023
12. A Profile of Eugene de Juan, MD

    Vom: 14.9.2023
13. An Implantation Telescope for Macular Disease

    Vom: 31.8.2023
14. Prevention of Vision Loss in the Gather Trial of IZERVAY

    Vom: 24.8.2023
15. GALE Long Term Extension Study for GA

    Vom: 14.8.2023
16. Pegcetacoplan (SYFOVRE) Clinical Update

    Vom: 11.8.2023
17. Faricimab in Neovascular AMD

    Vom: 3.8.2023
18. High Dose Aflibercept for Neovascular AMD

    Vom: 27.7.2023
19. Pegcetacoplan for Geographic Atrophy Update

    Vom: 20.7.2023
20. Ocular Therapeutix: A TKI and Hydrogel Implant

    Vom: 13.7.2023